Shares of Samsung C&T and Samsung Life Insurance surged following Samsung Biologics’ announcement to create a new company, Samsung Epis Holdings, as part of the group’s governance restructuring.
A detailed look at the ownership breakdown of Samsung Life Insurance (KRX:032830), examining the influence of institutional investors, insiders, and the general public on the company’s performance.
